Prediction of white-coat hypertension and white-coat uncontrolled hypertension using machine learning algorithm. [PDF]
Eur Heart J Digit Health, 2022 Aims The detection of white-coat hypertension/white-coat uncontrolled hypertension (WCH/WUCH) with out-of-office blood pressure (BP) monitoring is time- and resource-consuming.
Shih LC +8 more
europepmc +4 more sources
Current status of white coat hypertension: where are we? [PDF]
Therapeutic Advances in Cardiovascular Disease, 2020 White coat hypertension (WCH) is characterised by an elevated clinic blood pressure (BP) with normal ambulatory or home BP. It is well recognised in clinical practice and occurs in approximately one-third of untreated patients with elevated clinic BP ...
Gani Nuredini +3 more
doaj +3 more sources
The Utility of 24-h Ambulatory Blood Pressure Monitoring for the Diagnosis and Management of White Coat Hypertension in a Primary Care Setting [PDF]
Journal of Primary Care & Community Health, 2022 Objectives: Twenty-four-hour ambulatory blood pressure monitoring (ABPM) is recommended in patients with white coat hypertension (HTN) by national guideline, but was poorly utilized, and is available only in very limited subspecialty clinics.
Xiaolei Zhu +3 more
doaj +3 more sources
White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020. [PDF]
Hypertension, 2021 Few issues of modern cardiovascular medicine have been as controversial as the relationship between white-coat hypertension (WCH), that is, a common condition in which office blood pressure is elevated while out-of-office blood pressure (ambulatory blood
Mancia G +4 more
europepmc +2 more sources
Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population. [PDF]
J Hypertens, 2021 Objective: To study risk in white-coat hypertension (WCH) by measurement of coronary artery calcium score (CACS), carotid--femoral pulse-wave velocity (PWV) and carotid plaques.
Johansson MAK +5 more
europepmc +2 more sources
White Coat Hypertension & Cardiovascular Outcomes. [PDF]
Curr Hypertens RepThis review aims to inform the reader of the complexity of blood pressure responses when comparing blood pressure measured in the medical environment to that outside the medical environment.
Townsend RR, Cohen JB.
europepmc +2 more sources
Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis. [PDF]
J Clin Hypertens (Greenwich), 2020 Arterial damage of large arteries, addressed as c‐f PWV, is recognized as independent predictor for future cardiovascular disease. The aim of this study was to systematically investigate the association of the four hypertension phenotypes with carotid ...
Antza C +6 more
europepmc +2 more sources
Cardiovascular Events and Mortality in White Coat Hypertension. [PDF]
Ann Intern Med, 2019 Hypertension, the foremost preventable cause of disability and premature mortality worldwide (1), is diagnosed most commonly with in-office blood pressure (BP) measurements.
Cohen JB +3 more
europepmc +2 more sources
Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy
HYPERTENSION, 2020 Supplemental Digital Content is available in the text. The aim of this meta-analysis is to investigate whether white-coat hypertension (WCH) has an adverse effect on maternal, fetal, and neonatal outcomes.
Sonia Johnson +4 more
openalex +3 more sources
Association of thyroid function with white coat hypertension and sustained hypertension. [PDF]
J Clin Hypertens (Greenwich), 2019 This study aimed to explore the relationship of thyroid‐stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) levels with hypertension subtypes. 1056 euthyroid adults were included as research samples.
Cai P +6 more
europepmc +2 more sources